Huajun Chen, Guotong Xie
Expert Opinion on Drug Discovery
Complex challenges face all players in the oncology landscape, from health care policy leaders and third-party payers, to practicing physicians and nurses, to patients and their families. In these unsteady economic times, possible answers proposed by some may represent part of the problem to others. A distinguished panel assembled at the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care to explore the changing oncology landscape. This article is the synopsis of that discussion, with panelists shedding light on such issues as the astronomic cost of medical care, the need for clinicians to think outside the formulary, and the therapeutic decision-making process in the new world of "big data." © JNCCN-Journal of the National Comprehensive Cancer Network.
Huajun Chen, Guotong Xie
Expert Opinion on Drug Discovery
D.A. Shirley, Yu Zheng, et al.
Journal of Electron Spectroscopy and Related Phenomena
Tiziana Mordasini, Alessandro Curioni, et al.
ChemBioChem
Jesus J. Caban, Noah Lee, et al.
ISBI 2009